SCHEMBL4194795

SCHEMBL4194795

N#CCC1C=CN=C(OCCCc2ccccn2)N1c1nc2ccccc2s1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.32
RAB9A P51151 3/20 0.32
MEN1 O00255 2/20 0.32
MAPT P10636 2/20 0.32
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
GAA P10253 1/20 0.32
LMNA P02545 1/20 0.32
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
NPC1 O15118 2/20 0.31
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30
DRD2 P14416 1/20 0.30
ADRA2B P18089 1/20 0.30
ADRA2C P18825 1/20 0.30
DRD1 P21728 1/20 0.30
DRD4 P21917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4202435 0.90 RAB9A (0.32) ALDH1A1RAB9AMEN1MAPTKMT2A
SCHEMBL5613965 0.84 ATP4A (0.35) ALDH1A1RAB9AMEN1MAPTKMT2A
SCHEMBL5613855 0.84 ALDH1A1 (0.37) ALDH1A1RAB9AKDM4ESMN1; SMN2LMNA
SCHEMBL5613884 0.83 HTR1A (0.35) ALDH1A1RAB9AMEN1MAPTKMT2A
SCHEMBL5613944 0.82 MAPK8 (0.38) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL4193399 0.82 CYP1A2 (0.34) ALDH1A1RAB9AMEN1MAPTKMT2A
SCHEMBL4197137 0.82 MEN1 (0.41) ALDH1A1RAB9AMEN1MAPTKMT2A
SCHEMBL4190547 0.81 MAPK9 (0.39) ALDH1A1RAB9AMEN1MAPTKMT2A
SCHEMBL7707025 0.81 NAAA (0.32) RAB9AMEN1MAPTKMT2ALMNA
SCHEMBL4203404 0.81 PTGS1 (0.36) ALDH1A1RAB9AMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2026802-A2 JNK INHIBITORS FOR TREATMENT OF SKIN DISEASES Laboratoires Serono SA (CH) 2009-02-25 EP disclosed
WO-2007141224-A2 JNK INHIBITORS FOR TREATMENT OF SKIN DISEASES LABORATOIRES SERONO SA (CH) 2007-12-13 WO disclosed